Stow, OH, United States of America

Bing Yu

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Kent State University, Northeast Ohio Medical University. Active years: 2023-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bing Yu. Retrieved from https://idiyas.com/inventor/bing-yu-6ki61bzq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Bing Yu

Introduction

Bing Yu is a notable inventor based in Stow, Ohio, recognized for his significant contributions to the field of antimicrobial research. With a total of 2 patents, his work focuses on developing effective treatments against multidrug-resistant bacteria, which is a growing concern in modern medicine.

Latest Patents

One of Bing Yu's latest patents involves the rational design of lawsone derivatives as antimicrobials against multidrug-resistant strains. Naphthoquinone derivatives of lawsone have shown effectiveness against methicillin-resistant Staphylococcus aureus (MRSA). These compounds typically feature a substituent group at the 3-position of a specific naphthoquinone compound, such as 2-hydroxy-1,4-naphthoquinone. Notably, one derivative, referred to as compound 6c, exhibits potent antimicrobial activity comparable to that of the commercial antibiotics ofloxacin and ciprofloxacin against methicillin-sensitive strains. Furthermore, compound 6c demonstrates remarkable efficacy against MRSA strains that have developed resistance to both ofloxacin and ciprofloxacin, rivaling the effectiveness of vancomycin and daptomycin. Additionally, 6c is effective against vancomycin-intermediate and daptomycin non-susceptible strains of MRSA, showcasing a significantly improved drug resistance profile compared to conventional antibiotics.

Another patent by Bing Yu describes a method for treating skin wounds using glycoprotein nonmelanoma clone B (GPNMB) compositions. This method involves applying a therapeutically effective amount of a wound healing composition that includes GPNMB protein, an active peptide fragment, a GPNMB analog, or a GPNMB potentiating agent.

Career Highlights

Bing Yu has worked with reputable institutions such as Kent State University and Northeast Ohio Medical University. His research has contributed to advancements in antimicrobial treatments, addressing critical health challenges posed by drug-resistant bacteria.

Collaborations

Bing Yu has collaborated with notable colleagues, including Min-Ho Kim and Fayez Safadi, enhancing the scope and impact of his research.

Conclusion

Bing Yu's innovative work in antimicrobial research and wound healing showcases his commitment to addressing pressing medical challenges. His contributions are vital in the ongoing fight against drug-resistant infections and improving patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…